Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to target specific antigens such as prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. In addition to its TRACTr pipeline, the company is also developing a Tumor Activated Immunomodulator (TRACIr) — a costimulatory bispecific candidate designed to enhance T cell anti-tumor activity by engaging with programmed death-ligand 1 and CD28. Furthermore, a specific focus for their EGFR-TRACTr program is addressing epidermal growth factor receptor, a target prevalent in many cancer types and already a focus of numerous approved monoclonal antibody treatments. Janux Therapeutics, Inc. was founded in 2017 and is headquartered in La Jolla, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Janux Therapeutics, Inc.
NASDAQ:JANXHealthcare · Biotechnology
-2.34%$16.66
AH Close$16.66+0.00%vs close
AH Close$16.66+0.00%vs close
Mkt Cap$1.02B
Float42.55M
O/S61.14M
Inst Own99.3%
SI13.4%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$10M
Net Income-$113.63M
Total Assets$1.01B
Free Cash Flow-$83.28M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$22.14M
Total Equity$956.82M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in JANX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.01B
Liabilities$50.7M
Accounts Receivable$6.43M
Accounts Payable$4.97M
Inventory$0
PP&E (Net)$22.25M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $10M | $10.59M | $8.08M | $8.61M | $3.64M | $0 | $0 |
| YoY Growth | -5.6% | 31.0% | -6.1% | 136.8% | - | - | - |
| Cost of Revenue | $2.03M | $2.06M | $1.96M | $841K | $26.24M | $13K | $6K |
| Gross Profit | $7.97M | $8.53M | $6.13M | $7.77M | -$22.6M | -$13K | -$6K |
| Gross Margin | 79.7% | 80.5% | 75.8% | 90.2% | -621.4% | - | - |
| Research and Development | $125.9M | $68.39M | $54.92M | $53.44M | $26.24M | $3.04M | $3M |
| Selling, General, and Administrative | $41.77M | $41.05M | $26.14M | $22.26M | $10.33M | $1.79M | $772K |
| Other | -$2.03M | -$2.06M | -$1.96M | -$841K | -$26.24M | $0 | $0 |
| Total Operating Expenses | $165.64M | $107.38M | $79.11M | $74.86M | $10.33M | $4.83M | $3.77M |
| Operating Income (EBIT) | -$157.67M | -$98.85M | -$72.98M | -$67.09M | -$32.93M | -$4.84M | -$3.77M |
| Operating Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $206K | $233K |
| Interest Income | $44.04M | $29.85M | $14.69M | $4.03M | $257K | $206K | $233K |
| Other Income (Expense) | $44.04M | $29.85M | $14.69M | $4.03M | $257K | -$1.94M | -$233K |
| Income Before Tax (EBT) | -$113.63M | -$68.99M | -$58.29M | -$63.06M | -$32.67M | -$6.78M | -$4M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$113.63M | -$68.99M | -$58.29M | -$63.06M | -$32.67M | -$6.78M | -$4.24M |
| Net Income Margin | -1136.3% | -651.6% | -721.2% | -732.2% | -898.3% | - | - |
| Supplementary Data | |||||||
| EPS | -1.83 | -1.28 | -1.32 | -1.52 | -0.79 | -0.16 | -0.10 |
| Diluted EPS | -1.83 | -1.28 | -1.32 | -1.52 | -0.79 | -0.16 | -0.10 |
| Weighted Average OS | 61.97M | 53.75M | 44.02M | 41.47M | 41.24M | 41.61M | 41.61M |
| EBITDA | -$111.6M | -$66.93M | -$56.34M | -$62.22M | -$32.56M | -$6.57M | -$3.77M |
| EBITDA Margin | -1116.0% | -632.2% | -697.0% | -722.5% | -895.2% | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $52.33M | $430.61M | $19.2M | $51.43M | $35.58M | $7.81M | $658K |
| Short-Term Investments | $914.23M | $594.57M | $324.82M | $275.59M | $339.38M | $0 | $0 |
| Cash and Short-Term Investments | $966.57M | $1.03B | $344.03M | $327.02M | $374.96M | $7.81M | $658K |
| Accounts Receivable | $6.43M | $5.38M | $2.16M | $700K | $200K | $8M | $0 |
| Inventory | $0 | $0 | $0 | -$700K | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $5.42M | $1.85M | $0 | $0 |
| Total Current Assets | $975.89M | $1.03B | $349.24M | $332.44M | $377.02M | $16.06M | $658K |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $22.25M | $24.15M | $27.84M | $29.36M | $1.6M | $155K | $21K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $816K | $0 | $0 | $816K | $0 | $0 | $0 |
| Deferred Tax Assets | $5.96M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $2.61M | $3.7M | $3.33M | $1.39M | $1.21M | $0 | $0 |
| Total Long-Term Assets | $31.64M | $27.85M | $31.17M | $31.57M | $2.81M | $155K | $21K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.01B | $1.06B | $380.41M | $364.01M | $379.82M | $16.22M | $679K |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $4.97M | $4.03M | $2.42M | $2.16M | $2.46M | $428K | $267K |
| Short-Term Debt | $2.39M | $0 | $0 | $0 | $0 | $0 | $4M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $1.71M | $5.41M | $5.16M | $1.95M | $0 |
| Other Current Liabilities | $13.04M | $4.57M | $3.3M | $5.51M | $2.37M | $338K | $82K |
| Total Current Liabilities | $25M | $17.46M | $13.03M | $16.51M | $12.8M | $3.18M | $4.63M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $2.22M | $700K | $6.05M | $0 |
| Long-Term Deferred Tax Liabilities | $5.96M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $21.62M | $4M |
| Total Long-Term Liabilities | $25.7M | $21.28M | $23.02M | $26.76M | $700K | $27.67M | $4M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $50.7M | $38.73M | $36.06M | $43.27M | $13.5M | $30.86M | $8.62M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $60K | $59K | $46K | $42K | $41K | $1K | $1K |
| Retained Earnings | -$351.38M | -$237.76M | -$168.76M | -$110.47M | -$47.41M | -$14.74M | -$7.96M |
| Comprehensive Income & Other | $4.32M | $2.16M | $665K | -$1.53M | -$270K | $0 | $0 |
| Other Stockholders' Equity | $1.31B | $1.26B | $513.07M | $431.17M | $413.7M | $100K | $10K |
| Total Equity | $956.82M | $1.02B | $344.35M | $320.74M | $366.33M | -$14.64M | -$7.94M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.01B | $1.06B | $380.41M | $364.01M | $379.82M | $16.22M | $679K |
| Supplementary Data | |||||||
| Total Debt | $22.14M | $23.02M | $24.54M | $25.3M | $194K | $0 | $4M |
| Net Debt | -$30.2M | -$407.58M | $5.34M | -$26.12M | -$35.39M | -$7.81M | $3.34M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$113.63M | -$68.99M | -$58.29M | -$63.06M | -$32.67M | -$6.78M | -$4M |
| Depreciation & Amortization | $2.03M | $2.06M | $1.96M | $841K | $113K | $13K | $6K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $40.22M | $33.02M | $20M | $17.2M | $6.91M | $72K | $6K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $8M | -$8M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $831K | $0 | $0 |
| Accounts Payable | $977K | $1.58M | $277K | -$294K | $2.14M | $14K | $4K |
| Other Working Capital | $5.74M | -$899K | -$6.83M | $4.57M | -$2.13M | $8.38M | -$73K |
| Total Working Capital Change | $6.71M | $685K | -$6.55M | $4.28M | $8.84M | $389K | -$69K |
| Other Non-Cash Items | -$17.57M | -$10.59M | -$7.69M | -$2.18M | -$169K | $1.94M | $233K |
| Net Cash from Operating | -$82.23M | -$43.81M | -$50.58M | -$42.92M | -$16.98M | -$4.37M | -$3.83M |
| Investing Activities | |||||||
| Capital Expenditures | -$1.04M | -$359K | -$1.85M | -$6.45M | -$1.48M | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | -$64.71M | $339.48M | $0 | $0 |
| Purchases of Investments | -$705.22M | -$470.58M | -$317.34M | -$294.39M | -$473.63M | $0 | $0 |
| Sales of Investments | $405.28M | $212.91M | $278M | $359.1M | $134.15M | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $64.71M | -$339.48M | $0 | $0 |
| Net Cash from Investing | -$300.98M | -$258.02M | -$41.19M | $58.27M | -$340.96M | $0 | $0 |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | - | - | -$2.5M | -$4M |
| Common Stock Issuance | $5.29M | $698.27M | $56.53M | $500K | $204.17M | $0 | $0 |
| Common Stock Repurchases | -$347K | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $14.97M | $3.02M | $0 | $1.81M | $70K | $0 |
| Net Cash from Financing | $4.95M | $713.24M | $59.55M | $500K | $386.52M | $11.52M | $4M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$378.27M | $411.4M | -$32.22M | $15.84M | $28.59M | $7.16M | $172K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$82.23M | -$43.81M | -$50.58M | -$42.92M | -$16.98M | -$4.37M | -$3.83M |
| Capital Expenditure | -$1.04M | -$359K | -$1.85M | -$6.45M | -$1.48M | $0 | $0 |
| Free Cash Flow | -$83.28M | -$44.17M | -$52.42M | -$49.37M | -$18.46M | -$4.37M | -$3.83M |
| Cash at Beginning | $431.42M | $20.02M | $52.24M | $36.4M | $7.81M | $658K | $486K |
| Cash at End | $53.15M | $431.42M | $20.02M | $52.24M | $36.4M | $7.81M | $658K |